The executive team at Rhythm Pharmaceuticals has a history of experience in the biotech and pharmaceutical industries, with a focus on rare diseases. They have held positions at various companies, such as Krystal Biotech, Inc., Sanofi Genzyme, Genzyme Corp, Ra Pharmaceuticals, Novelion Therapeutics, Ziopharm Oncology, and Dyax. They have also been educated at prestigious institutions, such as the Massachusetts Institute of Technology and Harvard University.
View all